• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性充血的诊断与管理的多模式策略。一种心肾综合方法。

Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach.

作者信息

Rodríguez-Espinosa Diana, Guzman-Bofarull Joan, De La Fuente-Mancera Juan Carlos, Maduell Francisco, Broseta José Jesús, Farrero Marta

机构信息

Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain.

Department of Cardiology, Hospital Clínic of Barcelona, Barcelona, Spain.

出版信息

Front Physiol. 2022 Jul 8;13:913580. doi: 10.3389/fphys.2022.913580. eCollection 2022.

DOI:10.3389/fphys.2022.913580
PMID:35874534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304751/
Abstract

Refractory congestion is common in acute and chronic heart failure, and it significantly impacts functional class, renal function, hospital admissions, and survival. In this paper, the pathophysiological mechanisms involved in cardiorenal syndrome and the interplay between heart failure and chronic kidney disease are reviewed. Although the physical exam remains key in identifying congestion, new tools such as biomarkers or lung, vascular, and renal ultrasound are currently being used to detect subclinical forms and can potentially impact its management. Thus, an integrated multimodal diagnostic algorithm is proposed. There are several strategies for treating congestion, although data on their efficacy are scarce and have not been validated. Herein, we review the optimal use and monitorization of different diuretic types, administration route, dose titration using urinary volume and natriuresis, and a sequential diuretic scheme to achieve a multitargeted nephron blockade, common adverse events, and how to manage them. In addition, we discuss alternative strategies such as subcutaneous furosemide, hypertonic saline, and albumin infusions and the available evidence of their role in congestion management. We also discuss the use of extracorporeal therapies, such as ultrafiltration, peritoneal dialysis, or conventional hemodialysis, in patients with normal or impaired renal function. This review results from a multidisciplinary view involving both nephrologists and cardiologists.

摘要

难治性充血在急性和慢性心力衰竭中很常见,它对心功能分级、肾功能、住院率和生存率有显著影响。本文综述了心肾综合征的病理生理机制以及心力衰竭与慢性肾脏病之间的相互作用。虽然体格检查仍然是识别充血的关键,但目前正在使用生物标志物、肺、血管和肾脏超声等新工具来检测亚临床形式,并可能影响其管理。因此,提出了一种综合多模式诊断算法。治疗充血有几种策略,尽管关于其疗效的数据很少且尚未得到验证。在此,我们综述了不同利尿剂类型的最佳使用和监测、给药途径、根据尿量和尿钠排泄进行剂量滴定、实现多靶点肾单位阻断的序贯利尿剂方案、常见不良事件以及如何处理这些事件。此外,我们讨论了替代策略,如皮下注射呋塞米、高渗盐水和白蛋白输注以及它们在充血管理中作用的现有证据。我们还讨论了在肾功能正常或受损的患者中使用体外治疗,如超滤、腹膜透析或常规血液透析。这篇综述是由肾病学家和心脏病学家的多学科观点产生的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/47593d85c3b0/fphys-13-913580-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/ff18eb4eba06/fphys-13-913580-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/19c6b6528b38/fphys-13-913580-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/47593d85c3b0/fphys-13-913580-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/ff18eb4eba06/fphys-13-913580-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/19c6b6528b38/fphys-13-913580-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f5f/9304751/47593d85c3b0/fphys-13-913580-g003.jpg

相似文献

1
Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach.难治性充血的诊断与管理的多模式策略。一种心肾综合方法。
Front Physiol. 2022 Jul 8;13:913580. doi: 10.3389/fphys.2022.913580. eCollection 2022.
2
Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol.利尿剂抵抗性心力衰竭和超滤的作用:一项建议方案。
Rev Port Cardiol. 2023 Sep;42(9):797-803. doi: 10.1016/j.repc.2022.05.012. Epub 2023 Mar 21.
3
Overview of the Treatment of Congestion in Heart Failure.心力衰竭充血治疗概述。
Curr Pharm Des. 2023;29(20):1592-1601. doi: 10.2174/1381612829666230714153404.
4
Fluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis.液体超负荷作为心肾综合征管理的主要目标:对腹膜透析实践的启示
World J Nephrol. 2017 Jul 6;6(4):168-175. doi: 10.5527/wjn.v6.i4.168.
5
Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction.心力衰竭中的腹膜透析:关注肾脏和心室功能障碍。
Rev Cardiovasc Med. 2021 Sep 24;22(3):649-657. doi: 10.31083/j.rcm2203075.
6
Peritoneal Dialysis in Advanced Heart Failure Patients with Chronic Severe Congestion Resistant to Optimal Pharmacological Treatment.腹膜透析治疗对最佳药物治疗抵抗的慢性重度充血的晚期心力衰竭患者。
Turk Kardiyol Dern Ars. 2022 Apr;50(3):217-224. doi: 10.5543/tkda.2022.21157.
7
[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology].[心肾综合征患者的透析和超滤治疗:德国心脏病学会和德国肾脏病学会“心-肾”工作组的建议]
Dtsch Med Wochenschr. 2014 Feb;139(7):e1-8. doi: 10.1055/s-0033-1360037. Epub 2014 Feb 4.
8
Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.1型心肾综合征中潮式腹膜透析与超滤的比较:一项前瞻性随机研究。
Int J Artif Organs. 2019 Dec;42(12):684-694. doi: 10.1177/0391398819860529. Epub 2019 Jul 15.
9
Peritoneal Dialysis for Chronic Congestive Heart Failure.慢性充血性心力衰竭的腹膜透析
Blood Purif. 2015;40(1):45-52. doi: 10.1159/000430084. Epub 2015 Jun 24.
10
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.急性失代偿性心力衰竭的消肿治疗:超滤和利尿剂的心脏肾脏影响。
Am J Kidney Dis. 2011 Dec;58(6):1005-17. doi: 10.1053/j.ajkd.2011.07.023. Epub 2011 Oct 19.

引用本文的文献

1
Assessing volume status in heart failure: The role of renal duplex ultrasound in evaluating cardiorenal morbidity and heart failure mortality.评估心力衰竭中的容量状态:肾脏双功超声在评估心肾疾病和心力衰竭死亡率中的作用。
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):275-289. doi: 10.2478/jccm-2025-0029. eCollection 2025 Jul.
2
Domiciliary subcutaneous furosemide in patients with CKD and HF: a quality improvement project.慢性肾脏病合并心力衰竭患者的家庭皮下注射呋塞米:一项质量改进项目
BMJ Open Qual. 2025 Apr 10;14(2):e002984. doi: 10.1136/bmjoq-2024-002984.
3
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes.

本文引用的文献

1
Comprehensive Assessment of Fluid Status by Point-of-Care Ultrasonography.即时床旁超声全面评估液体状态。
Kidney360. 2021 May 27;2(8):1326-1338. doi: 10.34067/KID.0006482020. eCollection 2021 Aug 26.
2
Renal Compression in Heart Failure: The Renal Tamponade Hypothesis.心力衰竭中的肾脏压迫:肾脏填塞假说。
JACC Heart Fail. 2022 Mar;10(3):175-183. doi: 10.1016/j.jchf.2021.12.005. Epub 2022 Feb 9.
3
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
肺动脉高压与慢性肾脏病:患病率、病理生理学与转归。
Nat Rev Nephrol. 2024 Nov;20(11):742-754. doi: 10.1038/s41581-024-00857-7. Epub 2024 Jun 18.
4
Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle.三尖瓣反流、右心室功能与肾淤血:一个心肾三角区
Front Cardiovasc Med. 2023 Oct 4;10:1255503. doi: 10.3389/fcvm.2023.1255503. eCollection 2023.
5
Cardiovascular Consequences of Acute Kidney Injury: Treatment Options.急性肾损伤的心血管后果:治疗选择
Biomedicines. 2023 Aug 24;11(9):2364. doi: 10.3390/biomedicines11092364.
6
Edema formation in congestive heart failure and the underlying mechanisms.充血性心力衰竭中的水肿形成及其潜在机制。
Front Cardiovasc Med. 2022 Sep 27;9:933215. doi: 10.3389/fcvm.2022.933215. eCollection 2022.
钠-葡萄糖协同转运蛋白 2 抑制剂恩格列净治疗急性心力衰竭住院患者的多中心随机试验。
Nat Med. 2022 Mar;28(3):568-574. doi: 10.1038/s41591-021-01659-1. Epub 2022 Feb 28.
4
Diuretics in States of Volume Overload: Core Curriculum 2022.利尿剂在容量超负荷状态中的应用:2022 年核心课程。
Am J Kidney Dis. 2022 Aug;80(2):264-276. doi: 10.1053/j.ajkd.2021.09.029. Epub 2022 Feb 19.
5
Current use of inotropes according to initial blood pressure and peripheral perfusion in the treatment of congestive heart failure: findings from a multicentre observational study.根据初始血压和外周灌注情况使用正性肌力药物治疗充血性心力衰竭的现状:一项多中心观察性研究的结果。
BMJ Open. 2022 Jan 20;12(1):e053254. doi: 10.1136/bmjopen-2021-053254.
6
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.在 2 型糖尿病合并慢性肾脏病患者中,用非奈利酮治疗的心血管和肾脏结局:FIDELITY 汇总分析。
Eur Heart J. 2022 Feb 10;43(6):474-484. doi: 10.1093/eurheartj/ehab777.
7
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial.恩格列净对射血分数保留的心力衰竭的早期获益:来自EMPEROR-Preserved试验的见解
Eur J Heart Fail. 2022 Feb;24(2):245-248. doi: 10.1002/ejhf.2420. Epub 2022 Jan 18.
8
Levosimendan and Continuous Outpatient Support With Inotropes in Patients With Advanced Heart Failure: A Single-Centre Descriptive Study.左西孟旦和连续门诊支持与正性肌力药物在晚期心力衰竭患者:一项单中心描述性研究。
J Cardiovasc Pharmacol. 2022 Apr 1;79(4):583-592. doi: 10.1097/FJC.0000000000001214.
9
Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.呋塞米联合白蛋白与单纯呋塞米治疗的利尿效果比较:一项更新的系统评价和荟萃分析。
PLoS One. 2021 Dec 1;16(12):e0260312. doi: 10.1371/journal.pone.0260312. eCollection 2021.
10
Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function.住院急性心力衰竭患者容量超负荷逆转率:与长期肾功能的关系。
Am J Kidney Dis. 2022 Jul;80(1):65-78. doi: 10.1053/j.ajkd.2021.09.026. Epub 2021 Nov 27.